2. UroToday Home

Conference Highlights

SIU 2018

SIU 2018: Cardiovascular Disease and Cancer in Men

Seoul, South-Korea (UroToday.com) Ajay Nehra MD gave a summary of the most common causes of death in men, including cardiovascular disease, and the most common and lethal cancers among men.  Cardiovascular disease is the leading cause of mortality and morbidity worldwide. In the US, >30% of men have cardiovascular disease, and men account for over half of all cardiovascular-related deaths.

SIU 2018: Men’s Health: A Global Perspective

Seoul, South-Korea (UroToday.com) Men’s health is a discipline that promotes physical, mental, and social well-being of men throughout their life cycle (from boyhood to manhood) and addressing health problems related to them. In most parts of the world, health outcomes among boys and men continue to be substantially worse than among girls and women. This gender-based disparity in health has received little national, regional, or global acknowledgment or attention from health policy-makers or health-care providers. Unfortunately, to date, there is not much data that reports men’s health exclusively.

SIU 2018: BPH Panel: Enucleation Techniques: Aquablation

Seoul, South-Korea (UroToday.com) Peter Gilling, MD gave an overview of the impressive and novel aquablation technique for prostate adenomas in benign prostatic hyperplasia (BPH). Aquablation is a semi-automatic technique using robotic-assisted technology.

SIU 2018: BPH Panel: Enucleation Techniques: Holmium

Seoul, South-Korea (UroToday.com) Endoscopic enucleation of prostate adenoma for the treatment of benign prostate hyperplasia (BPH) has been endorsed by the European Association of Urology (EAU) guidelines.  Holmium laser enucleation of the prostate (HOLEP) is one of several enucleation techniques available today on the market.

SIU 2018: BPH Panel: Enucleation Techniques: Is There a Role for Open?

Seoul, South-Korea (UroToday.com)  Oussama Elhage, MD gave a talk on the utilization of the simple open prostatectomy for the treatment of prostatic adenoma in benign prostatic hyperplasia (BPH).  Current data show that prostates are getting larger. According to the European Association of Urology (EAU) guidelines, simple open prostatectomy should be considered for patients with large prostates (>80 cc). The American Urologic Association (AUA) guidelines have a very similar recommendation, recommending simple open prostatectomy for large prostates.

SIU 2018: BPH Panel: Enucleation Techniques: Robot-assisted Simple Prostatectomy

Seoul, South-Korea (UroToday.com) Thomas Guzzo, MD described the robotic surgical treatment of benign prostatic hyperplasia (BPH). According to both the American Urologic Association (AUA) and European Association of Urology (EAU) guidelines, open prostatectomy is recommended for patients with large prostates, greater than 80-100 cc. However, according to Dr, Guzzo, open prostatectomy is a morbid procedure with a high estimated blood loss, high rates or perioperative complications, and prolonged length of hospital stay.

SIU 2018: New Robotic Devices

Seoul, South-Korea (UroToday.com) John Davis, MD gave a summary of the new robotic devices that are in development and will be available in the next few years. Dr. Davis began with a description of how the robotic system has integrated with the health system. In the US, there is an emphasis on volume growth, shorter hospital stays, and improved quality metrics for high volume cases. However, in other countries, the patient might need to pay the difference, the government at a time pays the difference, and some cost pressure can lead to using older models or persistence with laparoscopy instead of using the robot.
Page 1 of 8